Godavari Drugs Ltd vs Panchsheel Organics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Godavari Drugs Ltd is ₹ 126.6 as of 06 May 15:30 . The P/E Ratio of Godavari Drugs Ltd changed from 8.4 on March 2021 to 15 on March 2025 . This represents a CAGR of 12.30% over 5 yearsThe P/E Ratio of Panchsheel Organics Ltd changed from 8.5 on March 2021 to 12.9 on March 2025 . This represents a CAGR of 8.70% over 5 years The Market Cap of Godavari Drugs Ltd changed from ₹ 34.45 crore on March 2021 to ₹ 65.86 crore on March 2025 . This represents a CAGR of 13.84% over 5 yearsThe Market Cap of Panchsheel Organics Ltd changed from ₹ 42.58 crore on March 2021 to ₹ 178.02 crore on March 2025 . This represents a CAGR of 33.12% over 5 years The revenue of Godavari Drugs Ltd for the Dec '25 is ₹ 22.45 crore as compare to the Sep '25 revenue of ₹ 27.28 crore. This represent the decline of -17.71% The revenue of Panchsheel Organics Ltd for the Dec '25 is ₹ 27.79 crore as compare to the Sep '25 revenue of ₹ 25.96 crore. This represent the growth of 7.05% The ebitda of Godavari Drugs Ltd for the Dec '25 is ₹ 2.75 crore as compare to the Sep '25 ebitda of ₹ 2.63 crore. This represent the growth of 4.56% The ebitda of Panchsheel Organics Ltd for the Dec '25 is ₹ 4.84 crore as compare to the Sep '25 ebitda of ₹ 4.15 crore. This represent the growth of 16.63% The net profit of Godavari Drugs Ltd changed from ₹ 1.63 crore to ₹ 0.76 crore over 7 quarters. This represents a CAGR of -35.34% The net profit of Panchsheel Organics Ltd changed from ₹ 3.43 crore to ₹ 3.68 crore over 7 quarters. This represents a CAGR of 4.10% The Dividend Payout of Godavari Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Panchsheel Organics Ltd changed from 20.04 % on March 2021 to 7.64 % on March 2025 . This represents a CAGR of -17.54% over 5 years .

About Godavari Drugs Ltd

Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India..
Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections.

About Panchsheel Organics Ltd

Incorporated as a private limited company in 1989, Panchsheel Organics Limited (POL) was later converted into a public limited company in 1992.
Company is manufacturer and exporter of Active Pharma Ingredients (APIs), Intermediates & Finished Formulations (both Human & Veterinary), having a wide experience of more than three decades in the healthcare field.
The Company was promoted in 1990 by the Turakhia Bros Group, in the field of Pharma Export-Import trading, dealing in a wide range of globally sourced, as well as indigenously manufactured, best-in-their-class life-saving medicines covering APIs, Intermediates, Specialty Chemicals, Hormones, Steroids etc.
Panchsheel is a technology based and market driven company creating a niche market for products. The Company is a manufacturer and exporter of Active Pharma Ingredients (APIs), Intermediates & Finished Formulations (both Human & Veterinary), having a wide experience of more than three decades in the healthcare field.

FAQs for the comparison of Godavari Drugs Ltd and Panchsheel Organics Ltd

Which company has a larger market capitalization, Godavari Drugs Ltd or Panchsheel Organics Ltd?

Market cap of Godavari Drugs Ltd is 128 Cr while Market cap of Panchsheel Organics Ltd is 151 Cr

What are the key factors driving the stock performance of Godavari Drugs Ltd and Panchsheel Organics Ltd?

The stock performance of Godavari Drugs Ltd and Panchsheel Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Godavari Drugs Ltd and Panchsheel Organics Ltd?

As of May 6, 2026, the Godavari Drugs Ltd stock price is INR ₹126.6. On the other hand, Panchsheel Organics Ltd stock price is INR ₹115.2.

How do dividend payouts of Godavari Drugs Ltd and Panchsheel Organics Ltd compare?

To compare the dividend payouts of Godavari Drugs Ltd and Panchsheel Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.